fromwww.theguardian.com
5 days agoMedicine
UK clinical trial into puberty blockers paused after medicines regulator raises concerns
The Pathways clinical trial of puberty blockers for children has been paused pending MHRA concerns about unquantified long-term biological harms and a recommended minimum age of 14.

